AI

AI based retinal diagnostic startup Leben Care gets funded by IP Ventures

The company provides AI based diagnostic and screening solutions, primarily known for automated, fast and affordable retinal screening. Leben Care will use the funds to strengthen its product, sales and marketing teams.

Singapore-based AI-based retinal diagnostic startup, Leben Care has raised angel funding from IP Ventures to fight avoidable blindness. The company provides AI based diagnostic and screening solutions, primarily known for automated, fast and affordable retinal screening. Leben Care will use the funds to strengthen its product, sales and marketing teams.

Leben Care enables automated analysis of retina image using AI algorithms that can be used by technicians, nurses, optometrists to conduct basic screening with minimal specialist intervention, delivering real-time reports. The company will also cater to areas such as Glaucoma and age-related macular edema.

With over 700 million people worldwide at the risk of retinal damage, 200 thousand ophthalmologists and only 35 thousand retina experts, there is a significant supply gap that LebenCare intends to fill with its scalable technology.

Leben Care is mentored by experts at Sankara Eye Foundation who have been closely involved in the product development cycle. It has already made a market entry in India, Japan, China, Singapore, Africa and Australia through partnerships with distributors & ophthalmology centers across these countries. The company also counts St.Johns Medical College, Giridhar Eye Insititute, Mach7, Telomeres, Cosmotec  and Tonghua Eye Hospital as some of its partners.

Nitin Srivastava, Co-founder, Leben Care, said: “We are excited to have the mentorship from IP Ventures coupled with their investment. We see tremendous value in being able to access the industry experts in IP Ventures team in this phase of building our company. Even the conversations during the entire due diligence process have helped us tremendously in shaping our approach. We are on a mission to fight avoidable blindness using AI and hope to make this technology available to millions who struggle to get access to basic screening. Our platform Netra.ai is intended to be the go to place for all Ophthalmology related AI solutions.”

Mitesh Shah, Co-founder of IP Ventures added: “In our country and even worldwide, there is a huge supply deficit when it comes to screening and diagnostic ophthalmology services. Leben Care is using AI and scalable technology to address this problem. Leben Care has a competent team and some great strategic partnerships. We are very excited to partner with them.”

Leave a Reply

Your email address will not be published. Required fields are marked *